← Back to headlines
Novo-Backed Respiratory Drugmaker Avalyn Pharma Files for US IPO
Avalyn Pharma, a respiratory drugmaker supported by Novo, has filed for an Initial Public Offering (IPO) in the United States. This move signals the company's intention to go public and raise capital.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Philippine Pharma Companies Pledge Medicine Price Freeze Amid Middle East Crisis
just now
Marcos Jr. Pledges New Hospitals for Military Veterans in Visayas and Mindanao
just now
Experts and CAPPA Warn of Chronic Funding Gaps Fueling Nigeria's Health Crisis
just now
Finnish Healthcare Choice Experiment Shows Higher-Income Individuals Visit Doctors More
30m ago